Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Texas Heart Institute designates this educational activity for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Estimated Study Time
The estimated time to complete this activity, including review of the materials and completion of the course assessment is 45 minutes.
If you previously completed and received credit for the live CME-sponsored grand rounds entitled, Top 10 Unresolved Questions in ICD Therapy, on January 16, 2009, please note that you will not receive credit for completing this activity. Participants who take part in an identical activity, even in order to validate learning or to clarify specific topics, cannot claim, nor will the Texas Heart Institute award, duplicate credit for the activity.
Term of Approval
February 9, 2009 through February 9, 2012. Continuation of CME credit from February 9, 2012 depends on a thorough review of the content for currency and accuracy.
In January 2009, this continuing medical education activity was reviewed for currency and accuracy of content by Patrick J. Hogan, MD, FACC, Director, Learning Resource Center and Co-Chairman, Medical Education Committee—Texas Heart Institute, Houston, Texas.
Disclosure of Relationships Faculty Disclosure
It is the intent of the Texas Heart Institute to ensure that its educational mission and its continuing medical activities in particular, should not be influenced by the special interests of individuals associated with its program.
In accordance with the guidelines of the Accreditation Council for Continuing Medical Education, faculty members have disclosed their relationships, either with one or more of the manufacturers of commercial products discussed, or with one or more of the corporate organizations offering educational grants for the live continuing medical education activity.
John P. DiMarco, MD, PhD discloses the following, relevant to this program: Grant/Research Support—Medtronic, Inc., Boston Scientific Corporation, and CV Therapeutics, Inc.; Consultant—Medtronic, Inc., Boston Scientific Corporation, Novartis, sanofi-aventis, and CV Therapeutics, Inc. He plans to discuss unlabeled or investigational uses of products.